These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33282946)

  • 1. Changes in Tumor Stem Cell Markers and Epithelial-Mesenchymal Transition Markers in Nonluminal Breast Cancer after Neoadjuvant Chemotherapy and Their Correlation with Contrast-Enhanced Ultrasound.
    Leng X; Huang G; Zhang L; Ding J; Ma F
    Biomed Res Int; 2020; 2020():3869538. PubMed ID: 33282946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS).
    Leng X; Huang G; Li S; Yao M; Ding J; Ma F
    PLoS One; 2021; 16(12):e0261138. PubMed ID: 34932597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential application value of contrast-enhanced ultrasound in neoadjuvant chemotherapy of breast cancer.
    Cao X; Xue J; Zhao B
    Ultrasound Med Biol; 2012 Dec; 38(12):2065-71. PubMed ID: 23062366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
    Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
    PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy.
    Wan CF; Liu XS; Wang L; Zhang J; Lu JS; Li FH
    Eur J Radiol; 2018 Jun; 103():118-123. PubMed ID: 29803376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
    Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L
    J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Response Assessed by Contrast-Enhanced Ultrasound in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
    Dong T
    Ultrasound Q; 2018 Jun; 34(2):84-87. PubMed ID: 29420367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging.
    Han X; Yang H; Jin S; Sun Y; Zhang H; Shan M; Cheng W
    Cancer Med; 2023 Jan; 12(2):1389-1398. PubMed ID: 35822639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-quadrant fast compressive tracking of breast ultrasound videos for computer-aided response evaluation of neoadjuvant chemotherapy in mice.
    Yan Y; Tang L; Huang H; Yu Q; Xu H; Chen Y; Chen M; Zhang Q
    Comput Methods Programs Biomed; 2022 Apr; 217():106698. PubMed ID: 35217304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
    Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.
    Saracco A; Szabó BK; Tánczos E; Bergh J; Hatschek T
    Acta Radiol; 2017 Apr; 58(4):394-402. PubMed ID: 27461224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating pathologic response of breast cancer to neoadjuvant chemotherapy with computer-extracted features from contrast-enhanced ultrasound videos.
    Zhang Q; Yuan C; Dai W; Tang L; Shi J; Li Z; Chen M
    Phys Med; 2017 Jul; 39():156-163. PubMed ID: 28690116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasonography and blue dye methods in detection of sentinel lymph nodes following neoadjuvant chemotherapy in initially node positive breast cancer.
    Wu X; Tang L; Huang W; Huang S; Peng W; Hu D
    Arch Gynecol Obstet; 2020 Sep; 302(3):685-692. PubMed ID: 32602000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
    Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
    Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Prediction of Response to Neoadjuvant Chemotherapy Using Quantitative Parameters on Automated Breast Ultrasound Combined with Contrast-Enhanced Ultrasound in Breast Cancer.
    Xie Y; Chen Y; Wang Q; Li B; Shang H; Jing H
    Ultrasound Med Biol; 2023 Jul; 49(7):1638-1646. PubMed ID: 37100671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells.
    Ilmer M; Mazurek N; Gilcrease MZ; Byrd JC; Woodward WA; Buchholz TA; Acklin K; Ramirez K; Hafley M; Alt E; Vykoukal J; Bresalier RS
    Breast Cancer Res; 2016 Sep; 18(1):97. PubMed ID: 27687248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer.
    Papadaki MA; Stoupis G; Theodoropoulos PA; Mavroudis D; Georgoulias V; Agelaki S
    Mol Cancer Ther; 2019 Feb; 18(2):437-447. PubMed ID: 30401696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer.
    Peng J; Pu H; Jia Y; Chen C; Ke XK; Zhou Q
    Medicine (Baltimore); 2021 May; 100(19):e25908. PubMed ID: 34106653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.